Ultragenyx Pharmaceutical shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $13M | 278k | 47.82 |
| 2023-09-30 | $9.8M | 276k | 35.65 |
| 2023-06-30 | $14M | 313k | 46.13 |
| 2023-03-31 | $108M | 250k | 433.11 |
| 2022-12-31 | $14M | 295k | 47.62 |
| 2022-06-30 | $18M | 295k | 59.67 |
| 2022-03-31 | $22M | 301k | 72.62 |
| 2021-12-31 | $27M | 322k | 84.08 |
| 2021-03-31 | $35M | 307k | 113.86 |
| 2020-12-31 | $32M | 231k | 138.42 |
| 2020-09-30 | $16M | 186k | 85.18 |
| 2020-06-30 | $12M | 149k | 78.95 |
| 2020-03-31 | $5.0M | 112k | 44.43 |
| 2019-12-31 | $2.4M | 57k | 42.71 |
| 2019-09-30 | $1.0M | 21k | 47.62 |
| 2019-06-30 | $1.3M | 18k | 71.43 |
| 2019-03-31 | $1.4M | 19k | 71.43 |
| 2018-12-31 | $649k | 14k | 47.62 |
| 2018-09-30 | $931k | 13k | 71.43 |
| 2018-06-30 | $1.2M | 17k | 71.43 |
| 2018-03-31 | $1.0M | 21k | 47.62 |
| 2017-12-31 | $1.0M | 22k | 47.62 |
| 2017-06-30 | $8.5M | 195k | 43.48 |
| 2017-03-31 | $21M | 244k | 86.96 |
| 2016-12-31 | $22M | 256k | 86.96 |
| 2016-09-30 | $20M | 282k | 70.96 |
| 2016-06-30 | $13M | 263k | 48.91 |
| 2016-03-31 | $29M | 258k | 111.11 |
| 2015-12-31 | $27M | 243k | 112.18 |
| 2015-09-30 | $0 | 182k | 0.00 |
| 2015-06-30 | $14M | 136k | 102.38 |
| 2015-03-31 | $13M | 206k | 62.12 |
| 2014-12-31 | $8.8M | 201k | 43.85 |
| 2014-09-30 | $11M | 196k | 56.61 |
| 2014-06-30 | $8.9M | 198k | 44.87 |
| 2014-03-31 | $8.9M | 182k | 48.90 |